Jump to content

News articles

wafer mpw run 6
2D-EPL / Electronics / Sensors

2D-EPL OFFERS A NEW EXPERIMENTAL MPW FROM GRAPHENEA SEMICONDUCTOR


Multi project wafer (MPW) runs are a common practice within the semiconductor ecosystem. Universities, R&D centres and start ups, which usually only need a few prototypes and operate with tight budgets, take advantage of this service to obtain devices at an affordable entry point. This is carried out with a mask sharing scheme, where devices with different geometries but shared device architecture are manufactured within the same mask; in this way, everyone gets a few devices but no one needs to purchase more devices than necessary. Now, Graphenea partners with the 2D Experimental Pilot Line (2D-EPL) to offer an MPW run with a novel process flow.

By Graphene Flagship / 18 April 2024
Graphene Flagship sign
Our project / Milestones / Innovation

Ten years of research, innovation and collaboration: the Graphene Flagship and the 2DM community


The Graphene Flagship was funded to ensure that Europe would maintain its lead in graphene research and innovation following the scientific breakthrough of graphene’s isolation at the University of Manchester. The European Commission launched the unprecedented long-term and large-scale Flagship research initiatives to tackle major challenges in science and technology, bringing positive changes that benefit society and the economy and advance European leadership in technology and industry. A decade on, we are proud to say that the Graphene Flagship has delivered on its promise. The clearly achieved objectives within scientific excellence, as well as societal and economic impact are detailed inside these pages.

By Graphene Flagship / 11 December 2023
doctor with graphene solutions MUNASET
MUNASET / Biomedical / Our project

MUNASET: A new Horizon Europe project kicked off


Proteases recently emerged as a promising new class of biomarkers with a broad diagnostic, prognostic and therapeutic potential for different human diseases including neurological and psychiatric diseases, several types of cancer and immune system disorders. However, there is a lack of tools for real-time activity analysis of disease-related protease biomarkers.

By Graphene Flagship / 06 December 2023